"The Retina Foundation of the Southwest is a Dallas nonprofit organization dedicated to preventing vision loss and restoring sight through innovative research and treatment. We believe that everyone deserves a lifetime of good vision."

During the past decade, Retina Foundation of the Southwest conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 10 clinical trials were completed, i.e. on average, 24.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 8 clinical trials were completed. i.e. 32% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Foundation of the Southwest" #1 sponsor was "ProQR Therapeutics" with 5 trials, followed by "Retina Foundation of the Southwest" with 5 trials sponsored, "Applied Genetic Technologies Corp" with 4 trials sponsored, "4D Molecular Therapeutics" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Foundation of the Southwest" #1 collaborator was "Foundation Fighting Blindness" with 5 trials as a collaborator, "Retina Foundation of the Southwest" with 5 trials as a collaborator, "National Eye Institute (NEI)" with 3 trials as a collaborator, "DSM Nutritional Products, Inc." with 2 trials as a collaborator and "McGill University" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Retina Foundation of the Southwest" are "Retinitis Pigmentosa" (15 trials), "Geographic Atrophy" (10 trials), "Macular Degeneration" (8 trials), "Amblyopia" (5 trials) and "Eye Diseases" (5 trials). Many other conditions were trialed in "Retina Foundation of the Southwest" in a lesser frequency.

Most popular intervention types in "Retina Foundation of the Southwest" are "Drug" (27 trials), "Other" (16 trials), "Biological" (7 trials), "Device" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Sham" (3 trials), "Galegenimab" (2 trials), "NT-501" (2 trials) and "QR-421a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Foundation of the Southwest" are 49 trials for "All" genders and 8 trials for "Male" genders.

Currently, there are 24 active trials in "Retina Foundation of the Southwest". 1 are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Retina Foundation of the Southwest, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Foundation of the Southwest, 10 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".